Literature DB >> 22498752

Epigenetic protein families: a new frontier for drug discovery.

Cheryl H Arrowsmith1, Chas Bountra, Paul V Fish, Kevin Lee, Matthieu Schapira.   

Abstract

Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases. At the molecular level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones. Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-containing proteins and proteins that bind to methylated histones. These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains. In this article, we discuss the known links with disease, basic molecular mechanisms of action and recent progress in the pharmacological modulation of each class of proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498752     DOI: 10.1038/nrd3674

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  190 in total

1.  Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis.

Authors:  Claas Janssen; Sonja Schmalbach; Sebastian Boeselt; Alexander Sarlette; Reinhard Dengler; Susanne Petri
Journal:  J Neuropathol Exp Neurol       Date:  2010-06       Impact factor: 3.685

2.  Vorinostat.

Authors:  Steven Grant; Chris Easley; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2007-01       Impact factor: 84.694

Review 3.  Sirtuin chemical mechanisms.

Authors:  Anthony A Sauve
Journal:  Biochim Biophys Acta       Date:  2010-02-02

4.  A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation.

Authors:  Daniela Kleine-Kohlbrecher; Jesper Christensen; Julien Vandamme; Iratxe Abarrategui; Mads Bak; Niels Tommerup; Xiaobing Shi; Or Gozani; Juri Rappsilber; Anna Elisabetta Salcini; Kristian Helin
Journal:  Mol Cell       Date:  2010-03-25       Impact factor: 17.970

Review 5.  Epigenetic opportunities and challenges in cancer.

Authors:  Jonathan D Best; Nessa Carey
Journal:  Drug Discov Today       Date:  2009-11-06       Impact factor: 7.851

6.  MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.

Authors:  Marielle Fournel; Claire Bonfils; Yu Hou; Pu Theresa Yan; Marie-Claude Trachy-Bourget; Ann Kalita; Jianhong Liu; Ai-Hua Lu; Nancy Z Zhou; Marie-France Robert; Jeffrey Gillespie; James J Wang; Hélène Ste-Croix; Jubrail Rahil; Sylvain Lefebvre; Oscar Moradei; Daniel Delorme; A Robert Macleod; Jeffrey M Besterman; Zuomei Li
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

7.  Identification and characterization of propionylation at histone H3 lysine 23 in mammalian cells.

Authors:  Bo Liu; Yihui Lin; Agus Darwanto; Xuehui Song; Guoliang Xu; Kangling Zhang
Journal:  J Biol Chem       Date:  2009-10-03       Impact factor: 5.157

8.  Abnormal histone modification patterns in lupus CD4+ T cells.

Authors:  Nan Hu; Xiangning Qiu; Yongqi Luo; Jun Yuan; Yaping Li; Wenzhi Lei; Guiying Zhang; Ying Zhou; Yuwen Su; Qianjin Lu
Journal:  J Rheumatol       Date:  2008-04-01       Impact factor: 4.666

9.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Authors:  Mark A Dawson; Rab K Prinjha; Antje Dittmann; George Giotopoulos; Marcus Bantscheff; Wai-In Chan; Samuel C Robson; Chun-wa Chung; Carsten Hopf; Mikhail M Savitski; Carola Huthmacher; Emma Gudgin; Dave Lugo; Soren Beinke; Trevor D Chapman; Emma J Roberts; Peter E Soden; Kurt R Auger; Olivier Mirguet; Konstanze Doehner; Ruud Delwel; Alan K Burnett; Phillip Jeffrey; Gerard Drewes; Kevin Lee; Brian J P Huntly; Tony Kouzarides
Journal:  Nature       Date:  2011-10-02       Impact factor: 49.962

10.  Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay.

Authors:  Aleksander M Grabiec; Olexandr Korchynskyi; Paul P Tak; Kris A Reedquist
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103

View more
  490 in total

Review 1.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1.

Authors:  Sabrina Castellano; Astrid Spannhoff; Ciro Milite; Fabrizio Dal Piaz; Donghang Cheng; Alessandra Tosco; Monica Viviano; Abdellah Yamani; Agostino Cianciulli; Marina Sala; Vincent Cura; Jean Cavarelli; Ettore Novellino; Antonello Mai; Mark T Bedford; Gianluca Sbardella
Journal:  J Med Chem       Date:  2012-11-02       Impact factor: 7.446

3.  Micro-editing mistake translates into a devastating brain tumor.

Authors:  Dan Dominissini; Ninette Amariglio; Gideon Rechavi
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

4.  Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1.

Authors:  Junghyun L Suh; Brian Watts; Jacob I Stuckey; Jacqueline L Norris-Drouin; Stephanie H Cholensky; Bradley M Dickson; Yi An; Sebastian Mathea; Eidarus Salah; Stefan Knapp; Abid Khan; Alexander T Adams; Brian D Strahl; Cari A Sagum; Mark T Bedford; Lindsey I James; Dmitri B Kireev; Stephen V Frye
Journal:  Biochemistry       Date:  2018-03-28       Impact factor: 3.162

5.  Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer.

Authors:  Satoshi Goda; Takayuki Isagawa; Yoko Chikaoka; Takeshi Kawamura; Hiroyuki Aburatani
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

6.  Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3.

Authors:  Lindsey I James; Victoria K Korboukh; Liubov Krichevsky; Brandi M Baughman; J Martin Herold; Jacqueline L Norris; Jian Jin; Dmitri B Kireev; William P Janzen; Cheryl H Arrowsmith; Stephen V Frye
Journal:  J Med Chem       Date:  2013-09-16       Impact factor: 7.446

Review 7.  Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.

Authors:  Jeremy D Osko; David W Christianson
Journal:  Bioorg Med Chem Lett       Date:  2020-02-11       Impact factor: 2.823

8.  DNA methylation and childhood asthma in the inner city.

Authors:  Ivana V Yang; Brent S Pedersen; Andrew Liu; George T O'Connor; Stephen J Teach; Meyer Kattan; Rana Tawil Misiak; Rebecca Gruchalla; Suzanne F Steinbach; Stanley J Szefler; Michelle A Gill; Agustin Calatroni; Gloria David; Corinne E Hennessy; Elizabeth J Davidson; Weiming Zhang; Peter Gergen; Alkis Togias; William W Busse; David A Schwartz
Journal:  J Allergy Clin Immunol       Date:  2015-03-11       Impact factor: 10.793

9.  Structure-Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains.

Authors:  Jacob I Stuckey; Catherine Simpson; Jacqueline L Norris-Drouin; Stephanie H Cholensky; Junghyun Lee; Ryan Pasca; Nancy Cheng; Bradley M Dickson; Kenneth H Pearce; Stephen V Frye; Lindsey I James
Journal:  J Med Chem       Date:  2016-09-19       Impact factor: 7.446

10.  Design, synthesis, and protein methyltransferase activity of a unique set of constrained amine containing compounds.

Authors:  Hao Zhou; Xin Che; Guochen Bao; Na Wang; Li Peng; Kimberly D Barnash; Stephen V Frye; Lindsey I James; Xu Bai
Journal:  Bioorg Med Chem Lett       Date:  2016-08-03       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.